Belmac's Alphanon
Executive Summary
NDA filing for the intranavel 2-Camphanone (camphor) hemorrhoid treatment planned for Dec. 15. Belmac's European licensee for Alphanon is Sanofi. A multicenter, double-blind, placebo controlled study involving 400 patients will begin in France and Germany in January, the company said ("The Pink Sheet," Oct. 12, 1987, p. 11)....